Clinical Trial

Telehealth Weight Loss Program for Breast Cancer Survivors

Study acronym: TWL
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a single-arm longitudinal group to examine patient-reported outcomes, body mass and mammographic density changes pre- and post- weight loss intervention of breast cancer survivors using video conferencing telehealth visits.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-07 -> 2027-07-31 2026-08-15
minor Completion pushed: 2026-12 -> 2027-12-31 2026-08-15
Trial Details
NCT Number NCT04855552
Lead Sponsor Abramson Cancer Center at Penn Medicine
Conditions Cancer Survivors, Cancer of Breast, Body Weight, Overweight and Obesity
Enrollment 22 participants
Start Date 2021-07-19
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-14